Current Medical Practice and the Food and Drug Administration: Some Evidence for the Existing Gap

Gregory R. Mundy, Lawrence Fleckenstein, John M. Mazzullo, Pavur R. Sundaresan, Michael Weintraub, Louis Lasagna

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The manner of use of three prescription drugs for hospitalized patients (cephalexin, allopurinol, and propranolol hydrochloride) was compared with the labeling recommendations that are approved by the Food and Drug Administration (FDA). Each drug was prescribed frequently for therapeutic indications not mentioned in the approved labeling (cephalexin in 78.3% of cases, allopurinol in 57.1%, and propranolol in 64.7%). Thus, a gap has developed between current medical practice and FDA-approved recommendations for therapeutic use. We suggest that for cephalexin and allopurinol, the FDA-approved recommendations agreed with the current medical literature, and the prescribing habits of physicians were inappropriate. With propranolol, however, the FDA-approved recommendations were lagging behind both good medical practice and the current medical literature. The implications of these findings are discussed with respect to prescribing habits and drug regulation.

Original languageEnglish (US)
Pages (from-to)1744-1748
Number of pages5
JournalJAMA: The Journal of the American Medical Association
Volume229
Issue number13
DOIs
StatePublished - Sep 23 1974
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Current Medical Practice and the Food and Drug Administration: Some Evidence for the Existing Gap'. Together they form a unique fingerprint.

Cite this